Therefore, we demonstrated that the combination of repeated ACTH administration with CMS to induce depression-like behavior and cognitive decline resulted in symptoms of imipramine resistance, as is discussed later in the manuscript: We abbreviated the combined treatment of ACTH and CMS as ACMS to distinguish it from the conventional CMS. This evidence concerns the gene POMC and depressive symptom measurement.